AJP Legacy AJP citation statistics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol 186: 13-18, 1956;
0002-9513/56 $5.00
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friedman, M.
Right arrow Articles by Byers, S. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedman, M.
Right arrow Articles by Byers, S. O.

Role of Hyperphospholipidemia and Neutral Fat Increase in Plasma in the Pathogenesis of Hypercholesteremia

Meyer Friedman 1 and Sanford O. Byers 1

1 From the Harold Brunn Institute for Cardiovascular Research, Mount Zion Hospital, San Francisco, California

The induction of a continuous state of hyperphospholipidemia in rats by the infusion of an emulsion of commercially pure soybean phosphatides quickly led to a rise in the plasma cholesterol of the animals. The degree of this rise moreover appeared to be directly dependent upon either the amount of phosphatides injected or the rise in plasma phospholipid occasioned by the injected phosphatides. The hypercholesteremia induced in this fashion was not affected by diversion of the animal's own intestinally derived cholesterol. A similar but less constantly induced hypercholesteremia also was observed to occur soon after the continuous injection of either a saturated or unsaturated type of neutral fat. Although such injection of fat also led to a rise in plasma phospholipid, this latter rise did not appear to be totally responsible for the hypercholesteremia induced. The results suggest not only that hypercholesteremia may be induced by experimental elevation of either plasma phospholipid or neutral fat but also that the hyperlipemia observed in various hypercholesteremic states may be involved in the latter's pathogenesis.

Note:
with the technical assistance of Clarence Omoto and Warren Hayashi

Submitted on December 27, 1955




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
G. H. Rothblat, M. de la Llera-Moya, V. Atger, G. Kellner-Weibel, D. L. Williams, and M. C. Phillips
Cell cholesterol efflux: integration of old and new observations provides new insights
J. Lipid Res., May 1, 1999; 40(5): 781 - 796.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. V. Rodrigueza, K. D. Mazany, A. D. Essenburg, M. E. Pape, T. J. Rea, C. L. Bisgaier, and K. J. Williams
Large Versus Small Unilamellar Vesicles Mediate Reverse Cholesterol Transport In Vivo Into Two Distinct Hepatic Metabolic Pools : Implications for the Treatment of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., October 1, 1997; 17(10): 2132 - 2139.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. V. Rodrigueza, K. J. Williams, G. H. Rothblat, and M. C. Phillips
Remodeling and Shuttling: Mechanisms for the Synergistic Effects Between Different Acceptor Particles in the Mobilization of Cellular Cholesterol
Arterioscler. Thromb. Vasc. Biol., February 1, 1997; 17(2): 383 - 393.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
D. A. ADAMS
The Pathophysiology of the Nephrotic Syndrome
Arch Intern Med, July 1, 1960; 106(1): 117 - 142.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 1956 by the American Physiological Society.